Sushi: I see your post got duped and I agree with your outlook, I don't think Geert will let this stock get de-listed as he has been working on that each time it was in question; the shocker would be if he exercises some of his warrants...we'd know about this within 2 days (insider reporting mandatory)...the rest of the information will be forthcoming within several weeks. It seems (to me) to be a strong hold here; I'm hopeful.
Ill add some catalysts -new licensing deals in more geograhies -upfront licensing payments -Takeover speculation(we are undervalued) -Tutes gain interest and agree undervalued taking a larger stake. This preceeds a public 13f filing and evidenced by price and volume increases. -CVM planning a secondary at a certain minimum price, the tutes will work the stock and get it to that minimum. -Another FDA prelim analysis emphasizing no safety concerns and the study may proceed. -additions/replacements at the C level or BOD.
Bottom line we are undervalued and it wont stay this way.
News 
Market Data 
Discover 
